University Delegates' Network

• Full Professor and Chair of the Department of Biochemistry at the Université de Montréal since 2008;
• His research addresses the virulence mechanisms of bacterial pathogens (in particular, type IV secretion systems) and aims at developing new antimicrobial medications. His laboratory also investigates the structure and cell dynamics of the selenosome, a macromolecular complex of proteins and RNA that is responsible for inserting selenocysteine into the cells of mammals;
• Dr. Baron holds a diploma (1990) and a Ph.D. (1993) in microbiology from Ludwig-Maximilians University in Munich, Germany. He pursued postdoctoral studies at the University of California, Berkeley in the United States from 1994 to 1997;
• He held the position of Assistant Professor/University Assistant in Munich, Germany from 1997 to 2002, and served as an Associate Professor at McMaster University, in Hamilton, Ontario from 2002 to 2008;
• Principal Investigator of the Cellular Dynamics of Macromolecular Complexes (CDMC) program funded by the CREATE (Collaborative Research and Training Experience) program of the Natural Sciences and Engineering Research Council of Canada (NSERC);
• Member of the Biochemistry and Molecular Biology – A (BMA) and the Microbiology and Infectious Diseases (MID) peer review committees of the Canadian Institutes of Health Research (CIHR).

• Professor at UQTR since 2005 and Canada Research Chair in cellular and molecular retrovirology.
• Dr. Berthoux began his research focusing on the HIV-1 nucleocapsid protein, experimenting on viral protein SUMOylation and on multimerization determinants of HIV-1 integrase. His primary area of investigation was retroviral restriction proteins of the TRIM5 family.
• Dr. Berthoux obtained his PhD from the École normale supérieure in Lyon, France, in 1998, under the direction of Jean-Luc Darlix. He completed his principal postdoctoral fellowship at Columbia University in New York City, in the laboratory of Jeremy Luban.
• Dr. Berthoux's work is funded by the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council (NSERC). He has also received funding from Sidaction and the ARC Foundation for Cancer Research (France), as well as from the American Foundation for AIDS Research (amfAR) and the Elisabeth Glaser Pediatric AIDS Foundation (United States).

• Dr. Bryanton, RN, PhD, is an Associate Professor at the UPEI School of Nursing.
• She teaches Nursing Research, Nursing of Childbearing Families, and a clinical course in Maternity nursing in the undergraduate program, and Quantitative Research in the Masters' program.
• Her research program focuses on perinatal health promotion, including women's perceptions of their birth experience, early parenting and parenting self-efficacy, breastfeeding, FASD prevention, and family-centered care.

• Professor and Associate Chair (Research), Department of Biochemistry and Biomedical Sciences, and Professor of Pathology and Molecular Medicine at McMaster University;
• Research interests include motility and biofilm formation by pathogenic bacteria; peptidoglycan metabolism and its coordination with assembly of cell-surface appendages; and antibiotic resistance and drug discovery;
• Dr. Burrows completed her Hon.B.Sc. Microbiology (1988), and Ph.D. Bacterial Genetics (1993) at the University of Guelph;
• Associate Professor of Surgery, University of Toronto and Scientist, Sick Kids Research Institute (1999-2005);
• Chair of the CIHR Microbiology and Infectious Diseases Peer Review Panel;
• CIHR New Investigator (2004-2009), Cystic Fibrosis Canada Fellow (1995-1998). NSERC Industrial Fellow (1993-1995).

• Dean & Professor, School of Health Studies;
• Adjunct Professor, University of Manitoba;
• Research Affiliate, Manitoba Centre for Nursing and Health Studies;
• Research interests and recently funded projects include: transition of new graduates to professional practice; and distance education for Aboriginal nursing students.

• Professor of Physiology, Faculty of Medicine;
• Has received both salary awards and operating grants from CIHR, and has served on CIHR's Endocrinology and New Investigator Award peer review committees.

• Dr. Donald, NP-PHC, PhD, is an Associate Professor at the Daphne Cockwell School of Nursing, Ryerson University.
• Affiliate Faculty with the Canadian Centre for Advanced Practice Nursing Research, McMaster University.
• Associate Professor, Status Only in the Lawrence S. Bloomberg Faculty of Nursing, University of Toronto.
• Associate Member, Graduate Department of Nursing Science at the University of Toronto, School of Graduate Studies.
• Nurse Practitioner-Primary Health Care, works on a locum basis in a busy community health center in Toronto.
• Earned a Graduate Diploma in Health Services and Policy Research and completed a two-year Canadian Health Services Research Foundation Postdoctoral Award.
• Research interests and recently funded projects include the education, integration, and evaluation of nurse practitioner and clinical nurse specialist advanced practice nursing roles in primary care, long-term care, acute care, and oncology settings, using mixed methods.
• Membership on the Board of Directors and on the Audit and Resources Committee for Health Quality Ontario.
• Membership on the Board of Directors and Chair of the Quality Improvement Committee for Central West Specialized Developmental Services.

• Professor of Physical Therapy and Graduate Program in Rehabilitation Sciences;
• Scientist, GF Strong Rehab Centre, Vancouver Coastal Health;
• Michael Smith Foundation for Health Research Senior Scholar in "Optimizing functional ability in neurological rehabilitation";
• CIHR New Investigator;
• Editorial Board, Physical Therapy Journal;
• Dr. Eng's research is funded by CIHR, Heart and Stroke Foundation of Canada, Michael Smith Foundation for Health Research, Ontario Neurotrauma Fund and Rick Hansen Man in Motion Foundation;
• She is co-Director of a CIHR Strategic Training Program in Rehabilitation and Quality of Life.

• Vice-Dean, Research and Innovation for the Schulich School of Medicine & Dentistry since March 2012;
• Research interests focused on mammalian nervous system development and pathology, specifically molecular genetics and neurochemistry approaches to investigate neuromuscular diseases. She has worked towards a better understanding of the pathogenesis of human neuromuscular disorders, both inherited and sporadic;
• Dr. Figlewicz completed her PhD (1979) in Biochemistry at Loyola University, Chicago, post-doctoral work at the National Institutes of Health and National Naval Medical Research Institute, both in Bethesda, Maryland;
• Subsequent to a Faculty Lecturer position based at the Department of Neurology, Montreal General Hospital, she joined the Departments of Neurology and Neurobiology & Anatomy at the University of Rochester as an Assistant Professor (1993), then Associate Professor (1996). She was an Associate Professor and Research Scientist in the Department of Neurology at the University of Michigan from 2002 to 2007; the ALS Society of Canada as Director of Research in 2006 and was promoted to Vice President, Research in 2009;
• She has led the implementation of ALS research, representing the Society worldwide within the scientific and research communities, and published over 80 papers in peer reviewed journals. She is Associate Editor for the Amyotrophic Lateral Sclerosis Journal, and a reviewer for the numerous neurology, neuroscience, and genetics journals as well as for Muscular Dystrophy Association of Canada, Muscular Dystrophy Association (USA), the Motor Neurone Disease Association (UK), the ALS Association (USA), the Medical Research Council of Canada et alia.

• Dr. Norbert Haunerland is the Associate Vice-President, Research and a Professor of Biological Sciences at Simon Fraser University (SFU). He is also affiliated with SFU's Department of Molecular Biology and Biochemistry and the Faculty of Health Sciences.
• Studying biochemistry at the University of Münster, Dr. Haunerland received his Ph.D. in 1982. Following post-doctoral work at Cornell and the University of Arizona, he joined SFU in 1989.
• With extensive experience in academic administration at SFU, Dr. Haunerland has served as Chair of the Department of Biological Sciences, as a long time member of Senate, and on various committees and task forces. He played a leading role in the establishment of the Faculty of Health Sciences at SFU, and has served on provincial and national higher education and research councils.
• As Associate Vice-President, Research, Dr. Haunerland advocates for SFU's research mission both internally and externally. He heads the Major Projects Office, which supports the development of proposals for major grant competitions, and is responsible for the administration of CFI grants and the Canada Research Chairs program for the University. Externally, Dr. Haunerland serves on several governance committees, including TRIUMF and WestGrid.
• His research is focused on proteins involved in lipid transport and metabolism, with a special interest in their role in gene regulation. He is known for his use of invertebrate model systems, and has extensive expertise in insect biochemistry and molecular biology.

• Michael Hayes joined the faculty at the University of Victoria in July, 2010 as the inaugural Director of Health Education and Research.
• Prior to coming to UVic, spent 22 years at Simon Fraser University in the Department of Geography and, in 2004, as a founding member of the Faculty of Health Sciences.
• co-founding editor of the journal Health and Place.
• At UVic, I have appointments in the School of Public Health and Social Policy in the Faculty of Human and Social Development, in the Division of Medical Sciences, in addition to my appointment in the Department of Geography.
• was a non-governmental representative on the Federal- Provincial- Territorial Advisory Committee on Population Health (2001-2006) and a member the Public Health Agency of Canada Expert Advisory Committee on Population Health Promotion (2006-2008).
• My research interests concern social geographies of health from a life-course perspective. I am particularly interested in health inequities and urban structure, social gradients in health outcomes, disability and public policy. I have also done research on childhood obesity and on newspaper coverage on 'health' in Canada. I have co-edited 3 books.

• Dr. Shanthi Johnson is a Professor and Associate Dean (research and graduate studies) at the Faculty of Kinesiology and Health Studies, University of Regina.
• She has fellow status with Dietitians of Canada and the American College of Sports Medicine.
• Her research program involves health promotion and falls prevention among older adults with a multidisciplinary perspective, and is funded by agencies such as the Canadian Institutes of Health Research, the Saskatchewan Health Research Foundation, and the Canadian Foundation for Innovation.
• Dr. Johnson has given over 150 presentations at national and international conferences, media interviews, and has several publications.
• She has served, and is currently serving on several boards and committees at the provincial and international levels.
• She is also a reviewer/associate editor for health, nutrition, exercise sciences and aging journals, and granting agencies such as the Canadian Institutes of Health Research, Canada Foundation for Innovation, the UK Review Panel on Aging, and the European Commission.

• currently Associate Dean (Research) in the Faculty of Medicine and Professor in the Department of Microbiology & Immunology within the Faculty of Medicine at Dalhousie University (Halifax, Nova Scotia).
• Dr. Johnston's research program is a collaborative effort with Dr. Richard Singer (Department of Biochemistry & Molecular Biology) and involves using the approaches of molecular genetics and biochemistry to investigate the regulation of cellular processes such as control of cell proliferation and membrane trafficking. The Johnston/Singer lab utilizes the genetic and molecular facility of the budding yeast, Saccharomyces cerevisiae.
• was recruited to the Department of Microbiology at Dalhousie University, and over the intervening 30 years, Dr. Johnston's collaborative genetics program has been funded continuously by the MRC (now CIHR).
• has served as a member of several grant review panels including Cancer A and Genetics within CIHR and Panels B and F within the National Cancer Institute of Canada (now called The Canadian Cancer Society Research Institute).
• In 1992, Dr. Johnston was made a Terry Fox Cancer Research Scientist of the NCIC, and in 1995 he joined, and subsequently chaired, the Advisory Committee on Research (ACOR) of the NCIC, the senior committee of the NCIC that oversees all of the NCIC funding programs. In 2004 to 2006 served as President of the NCIC.
• From 2001 to 2006 Dr. Johnston also served as a member of the Institute Advisory for the CIHR Institute of Cancer Research.

• Currently Dean of Research and Graduate Studies, Cape Breton University;
• Professor of Chemistry;
• Canada Research Chair in Molecular Spectroscopy, 2006 - 2011;
• Adjunct Professor, Dalhousie University and Memorial University;
• BSc (Memorial University), PhD (University of Alberta);
• NSERC Postdoctoral fellow (University of Ottawa);
• CBU NSERC Representative 2001 - 2004, 2009 - 2010;
• Science Atlantic Chemistry Committee Chair 1999 - 2002;
• Research funded by NSERC, American Chemical Society, CFI, Nova Scotia Research and Innovation Trust, CRC;
• Research Interests focus on weak interactions in liquids.

• Published 112 peer-reviewed papers to date, 18 reviews and 171 conference abstracts;
• Inventor - holds 4 issued US patents;
• 2009 - Review member of the NIH Drug Discovery and Mechanisms of Antimicrobial Resistance (DDR) Study Section;
• 2008 - Chair of organizing committee of the FASEB Summer Conference on Microbial Polysaccharides of Medical, Agricultural and Industrial Importance, held in Carefree, AZ;
• 2006 - Member of the organizing committee of the FASEB Summer Conference on Microbial Polysaccharides of Medical, Agricultural and Industrial Importance, held in Tucson, AZ;
• 2006-2011 - Editorial Board Member, Journal of Bacteriology;
• 2006 - recipient of the Roche Diagnostic/Canadian Society of Microbiologists Award;
• 2005 - elected as a Fellow of the American Academy of Microbiology (FAAM);
• 2005 - Member, CIHR Team Grant - "Letter of Intent" Review Committee (Biomedical Research panel);
• 2003-2010 - Canada Research Chair (Tier I) in Cystic Fibrosis and Microbial Glycobiology;
• 2004 - recipient of University of Guelph Faculty Association Teaching Award;
• 2003-2010 - Ontario Distinguished Researcher Award, Ontario Innovation Trust;
• 2003-2004 - Committee member, Medical Review Committee, Ontario Research Development Challenge Fund (ORDCF);
• 2002 - recipient of the CBS Awards for Excellence in Teaching;
• 2001-2004 - Member, Canadian Institutes of Health Research, Microbiology and Infectious Diseases Grants review committee.

• A Chercheur national of the Fonds de recherche du Québec – Santé (FRQS) from 2005-2010, Dr. Leduc is a professor at the Department of Pharmacology of the Université de Sherbrooke Faculty of Medicine and Health Sciences since 1992;
• His expertise lies in the structure and function of a novel family of proteolytic enzymes, the type II transmembrane serine proteases and in the structure and function of G protein-coupled receptors;
• Born in Montreal, Richard Leduc completed his Master's Degree in Pharmacology / Chemistry at the Department of Pharmacology of the Université de Sherbrooke in 1982, PhD in Clinical Sciences at the Institut de recherches cliniques de Montréal (IRCM) affiliated with the Université de Montréal in 1988, and postdoctoral training at the Vollum Institute, Oregon Health & Science University, from 1989-1992;
• Dr. Leduc is the co-founder of the Club de recherche sur les récepteurs couplés aux protéines G, a provincial group of scientists working in the field of G protein-coupled receptors (GPCR) who meet every year with scientists from Ontario and the Northeast United States to exchange ideas and establish collaborations. He is also President of the Committee on Therapeutic Targets Identification and Validation of the Réseau québécois de recherche sur l'usage des médicaments (RQRUM), Fonds de recherche du Québec – Santé (FRQS).

• Professor and Chair, Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa;
• Canada Research Chair in Human Genome Epidemiology;
• Dr. Little's PhD, from Aberdeen University, was on problems of ascertainment of congenital anomalies. Subsequently, he worked for the EUROCAT Central Registry in Brussels (Belgium), as a lecturer in epidemiology in Nottingham University, as an epidemiologist in the International Agency for Research on Cancer in Lyon, and as Professor of Epidemiology at Aberdeen University, during which he spent a sabbatical year at the Office of Genomics and Disease Prevention, CDC, Atlanta;
• His current research includes empirical work on potential biases in genetic association studies, harmonization of biobanks, the potential value of germline genetic profiling in prediction of risk for colorectal cancer, the potential value of information on family history in predicting risk for chronic disease, potential value of information on HPV and other factors in management of women with low-grade cervical abnormalities, and etiology of cleft lip and palate;
• Associate Editor, American Journal of Epidemiology; Editorial Boards; Human Genetics; Public Health Genomics; Kuwait Medical Journal;
• Member of Priority and Planning Committee, Institutes of Genetics and of Population and Public Health, CIHR.

• Dr. McGrath received her PhD in Clinical Psychology from Bowling Green State University, Ohio, and her M.P.H. in Epidemiology from University of Pittsburgh, Pennsylvania. She completed post-doctoral training in Cardiovascular Behavioral Medicine at the University of Pittsburgh.
• She is an Associate Professor in the Department of Psychology at Concordia University and the Director of the Pediatric Public Health Psychology Laboratory.
• Her research broadly focuses on the pathogenesis of subclinical cardiovascular disease markers across childhood and adolescence as mediated by potential behavioral, environmental, and psychological mechanisms. She is particularly interested in health disparities and how socioeconomic inequalities are associated with cardiovascular health behaviors in youth. She holds two CIHR operating grants to investigate these issues.
• Dr. McGrath serves on the CIHR peer-review committee for Psychosocial, Sociocultural, and Behavioral Determinant.

• Associate Dean (Research) in the Faculty of Medicine at McGill University since 2008, is involved in many different activities that help promote research excellence at McGill as well as the careers of Faculty members;
• Completed her PhD in Immunology at the University of Toronto and post-doctoral studies at the University of Texas Health Sciences Centre in Dallas;
• Recruited to McGill in 1987, has had a research laboratory at the Research Institute of the McGill University Health Centre (MUHC) since that time;
• President of Immunology Montreal (since 2007), was instrumental in attracting and organizing the highly successful International Congress of Immunology held in Montreal in 2004. Immunology Montreal links McGill with University of Montreal and Institut Armand-Frappier to promote collaboration and education about immunology;
• As President of Immunology Montreal, spearheaded a community outreach activity which won a major prize in an international competition conducted by the European Federation of Immunological Societies.

• Michael Owen, Ph.D., is Associate Provost, Research and Professor, Faculty of Education at the University of Ontario Institute of Technology.
• Prior to joining UOIT, Owen was Vice-President Research and Graduate Studies and Professor in the Faculty of Liberal Studies, Ontario College of Art and Design.
• He also has held positions of Professor and Associate Vice-President Research & International Development, Brock University, and Director of Research Services at Brock University, Ryerson University and the University of Saskatchewan and Assistant to the Vice-President Academic at Athabasca University.
• He has extensive experience in research management and administration and leadership in scholarly associations in Canada.
• He has served as Vice-President Research Dissemination of the Canadian Federation of Humanities and Social Sciences, President of the Society of Research Administrators International (SRA International), President of the Canadian Society for Church History (CSCH) and President of the Canadian Association for Foundations of Education (CAFE).
• Owen's research interests are: history of research ethics in Canada, research ethics education, research administration, technology transfer, educational history and Canadian church history.

• Associate Dean for clinical research in the Faculty of Medicine, Clinician Scientist and Professor of Medicine at Memorial University of Newfoundland, and Staff Rheumatologist at Eastern Health, Newfoundland & Labrador;
• Involved in genetics research, he has identified several novel susceptibility genes in psoriasis and psoriatic arthritis, as well as new genetic markers for disease progression and pharmacogenetics in inflammatory rheumatic disease;
• Dr. Rahman completed his medical school and internal medicine training at Memorial University of Newfoundland, and rheumatology fellowship and graduate training in genetic epidemiology at the University of Toronto;
• He joined the Faculty of Medicine at Memorial in 1999 and has initiated various large scale interdisciplinary projects such as the Newfoundland Genealogical Kit, which was completed through collaboration with the Government of Newfoundland and Labrador, the Newfoundland and Labrador Center for Health Information, IBM, the Discipline of Genetics and numerous investigators at Memorial University.

• Professor and Chair, Department of Biology, University of Waterloo since January, 2009.
• Formerly a Senior Scientist at the Ontario Cancer Institute and Professor, Medical Biophysics, University of Toronto and previous to that with the Institute of Biological Sciences, National Research Council Canada, Ottawa.
• Undergraduate education: University of Pennsylvania, DPhil: University of Oxford, Postdoc: MIT (G.A. Petsko).
• Dr. Rose's area of research is in structure/function studies of enzymes associated with human health, particularly glycosidases. He is studying the basic mechanisms by which these enzymes perform their functions in maintaining health or causing disease, and how those functions might be modulated by inhibitors. The main technical areas in Dr. Rose's laboratory are X-ray crystallography and recombinant expression of proteins in different systems.

• PhD (Waterloo), PDF (University of Saskatchewan).
• Associate professor in the School of Recreation Management and Kinesiology.
• Dr. Shields' program of research examines the psychosocial determinants and consequences of physical (in)activity, with a primary focus on how the health care professional-client interaction may influence adherence among symptomatic (e.g., cardiac rehabilitation patients, diabetes patients) and asymptomatic populations.
• His work is among the first to examine the impact of relational efficacies on physical activity-related thoughts and behaviour, and includes work on group-based exercise in healthy populations as well as a province wide investigation of the role diabetes educators play in promoting physical activity for those with diabetes.
• Dr. Shields holds or has held funding as PI or Co-I from multiple granting agencies including CIHR, SSHRC, CFI, the Heart and Stroke Foundation, and the Lawson Foundation.
• he is an active reviewer for numerous health, exercise and psychology journals and has been a grant reviewer for SSHRC and the Nova Scotia Health Research Foundation.
• Recently, Dr. Shields was asked to serve as a member of the Scientific Advisory Committee for the Heart and Stroke Foundation of Nova Scotia.

• Canada Research Chair in Atlantic Canada Studies at Saint Mary's University since 2003;
• Primary research interests involve interdisciplinary approaches to understanding health, illness and disease, and the social organization of health care work;
• Dr. Twohig was a member of the Faculty of Medicine at Dalhousie University;
• His research has been published in Canadian Family Physician, Canadian Medical Association Journal, the British Medical Journal, the American Journal of Bioethics, Acadiensis and other journals;
• He is the author of Labour in the Laboratory (2005) and Challenge and Change (1998) and the coeditor of a six essay collections on health, illness and disease.

Dr. Elaine C. Wiersma
Lakehead University

• Associate Professor in the Department of Health Sciences.
• Dr. Wiersma’s work focuses on dementia and quality of life, aging and quality of life, and rural health, with a particular emphasis on self-management for people living with dementia.
• Her research expertise is in participatory action research, community based research, and qualitative methodologies.
• Research is funded by CIHR, SSHRC, and the Alzheimer Society of Canada.

• Professor in the Department of Cell Biology in the Faculty of Medicine and Dentistry at the University of Alberta.
• Received his undergraduate degree in Biochemistry from Michigan State University and his Ph.D. from the Rockefeller University in New York City under the supervision of Dr. Günter Blobel.
• His work has focused on the cell nucleus, a defining feature of a eukaryotic cell and the place where the cell's genetic material is housed.
• Dr. Wozniak's work has contributed to defining the machinery in cells that controls the movement of proteins into and out of the nucleus, including factors that regulate this transport machinery, and understanding how these factors influence gene expression and processes occurring during cell division and differentiation.
• Dr. Wozniak has been the recipient of various awards including Scholarship, Senior Scholar, and Scientist awards from Alberta Heritage Foundation for Medical Research, a Medical Research Council of Canada Scientist Award, Merck Frosst Prize for independent research in biochemistry and molecular biology from the Canadian Society for Biochemistry, Molecular, and Cellular Biology, and a Howard Hughes Medical Institute International Research Scholar Award.

• Dr. Zamponi is currently the Senior Associate Dean for Research in the Faculty of Medicine at the University of Calgary.
• He is one of the leading experts in the field of voltage gated calcium channels, with a specific interest in the role of calcium channels in the development of chronic pain.
• He received his undergraduate training in Engineering Physics at the Johannes Kepler University, followed by a PhD in Neuroscience at the University of Calgary.
• After a postdoctoral fellowship at the University of British Columbia, he took up a faculty position at the University of Calgary where he subsequently chaired the Department of Physiology and Pharmacology.
• Dr. Zamponi has published close to 200 peer reviewed articles and holds numerous US patents on new pain therapeutics.
• Dr. Zamponi is a former holder of a CIHR Investigator Award, and is an Alberta Innovates-Health Solutions Scientist and Canada Research Chair.
• He is a Fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences.